The Potential Role of Circulating Inflammatory Cells in Predicting the Safety, Efficacy and Immune-related Adverse Events of Immune Check-point Inhibitors: A Narrative Review

Gastroenterology Medicine & Research The Potential Role of Circulating Inflammatory Cells in Predicting the Safety, Efficacy and Immune-related Adverse Events of Immune Check-point Inhibitors: A Narrative Review Tibera K Rugambwa1,2*, Omar Abdihamid2,3,4, Miriam Kessy5 and Alphonce MK Nyalali6,7,8 1Department of Internal Medicine, Mbeya Zonal Referral Hospital and Mbeya College of Health and Allied Sciences, University of Dar-es-salaam, Mbeya, Tanzania 2Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China 3HCGCCK Cancer Centre, Nairobi, Kenya 4Garissa Cancer Centre, Garissa County, Kenya 5Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan, China 6Department of Neurosurgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China. 7Department of Neurosurgery, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan 250012, China 8Department of Surgery, Songwe Regional Referral Hospital, Songwe 23, Mbeya, Tanzania *Corresponding author:Tibera K Rugambwa, Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China Submission:March 09, 2023;Published: March 30, 2023 DOI: 10.31031/GMR.2023.07.000665 ISSN 2637-7632Volume7 Issue3